A recent study has found that small improvements in HbA1c in people with diabetes can reduce health complications and the economic costs associated with treating them. This research was completed in the UK and analyzed data from adults living with type 1 and type 2 diabetes. Findings showed that improved glycemic control could potentially lead to preventing one million microvascular complications. These included diabetic foot diseases, such as neuropathy, amputations, and foot ulcers.
The cost savings of improved glycemic control were also thought to be substantial. Cost reductions associated with avoiding diabetic complications over 25 years were projected to reach almost $8 billion.
These findings were published in Diabetic Medicine on April 15, 2016.